NEXARIS
LIVE

Serial Number

79233295

Owner

SIEMENS HEALTHINEERS AG

Attorney

Lisa M. DuRoss

Filing Date

Apr 23, 2018

Add to watchlist:

No watchlists yet
View on USPTO

NEXARIS Trademark

Serial Number: 79233295 • Registration: 5619782

NEXARIS is a trademark filed by SIEMENS HEALTHINEERS AG on April 23, 2018. The trademark is classified under Class 10 (Medical Apparatus). The application is currently registered and active.

Owner Contact Info

SIEMENS HEALTHINEERS AG (346 trademarks)

SIEMENSSTRASSE 3
FORCHHEIM 91301 , DE

Entity Type: 25

SIEMENS HEALTHCARE GMBH (383 trademarks)

Munchen 80333 , DE

Entity Type: 03

Trademark Details

Filing Date

April 23, 2018

Registration Date

December 4, 2018

Published for Opposition

September 18, 2018

Goods & Services

Medical apparatus and instruments and parts therefor, in particular for medical imaging

Filing History

NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
Nov 18, 2024 NA75
REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.
Nov 18, 2024 C75A
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Nov 13, 2024 APRE
NEW REPRESENTATIVE AT IB RECEIVED
Sep 7, 2024 NREP
CHANGE OF OWNER RECEIVED FROM IB
Jul 5, 2024 CHLD
TEAS SECTION 71 & 15 RECEIVED
Mar 20, 2024 ES75
NEW REPRESENTATIVE AT IB RECEIVED
Sep 24, 2021 NREP
NOTIFICATION PROCESSED BY IB
Feb 1, 2019 GPNX
FINAL DISPOSITION NOTICE SENT TO IB
Jan 16, 2019 FICS
FINAL DISPOSITION PROCESSED
Jan 16, 2019 FIMP
GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Jan 3, 2019 GPAR
REGISTERED-PRINCIPAL REGISTER
Dec 4, 2018 R.PR
NOTIFICATION PROCESSED BY IB
Sep 21, 2018 GPNX
PUBLISHED FOR OPPOSITION
Sep 18, 2018 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Sep 5, 2018 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Sep 5, 2018 OP2R
NOTICE OF PUBLICATION
Aug 29, 2018 NPUB
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 15, 2018 CNSA
ASSIGNED TO EXAMINER
Aug 13, 2018 DOCK
APPLICATION FILING RECEIPT MAILED
Jun 12, 2018 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 8, 2018 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
May 31, 2018 REPR